迈向甲状腺癌的精准医学 - Suppr

Suppr

超能文献

Towards precision medicine in thyroid cancer.

作者信息

Xiao Haipeng, Liu Rengyun, Yu Shuang

机构信息

Department of Endocrinology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

出版信息

Ann Transl Med. 2020 Oct;8(19):1212. doi: 10.21037/atm-20-6450.

DOI:10.21037/atm-20-6450

PMID:33178744

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7607071/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d495/7607071/16ee8d53db9d/atm-08-19-1212-fa.jpg

相似文献

Towards precision medicine in thyroid cancer.迈向甲状腺癌的精准医学

Ann Transl Med. 2020 Oct;8(19):1212. doi: 10.21037/atm-20-6450.

Nodular Thyroid Disease and Thyroid Cancer in the Era of Precision Medicine.精准医学时代的结节性甲状腺疾病与甲状腺癌

Eur Thyroid J. 2017 Apr;6(2):65-74. doi: 10.1159/000457793. Epub 2017 Mar 3.

Precision Medicine Approach to Anaplastic Thyroid Cancer: Advances in Targeted Drug Therapy Based on Specific Signaling Pathways.间变性甲状腺癌的精准医学方法：基于特定信号通路的靶向药物治疗进展

Acta Med Iran. 2017 Mar;55(3):200-208.

Thyroid dysfunction in the era of precision medicine.精准医学时代的甲状腺功能障碍

Endocrinol Nutr. 2016 Aug-Sep;63(7):354-63. doi: 10.1016/j.endonu.2016.04.009. Epub 2016 Jun 3.

G Protein-coupled Receptors in Radioiodine-refractory Thyroid Cancer in the Era of Precision Medicine.精准医学时代的放射性碘难治性甲状腺癌中的 G 蛋白偶联受体。

J Clin Endocrinol Metab. 2021 Jul 13;106(8):2221-2232. doi: 10.1210/clinem/dgab343.

Precision Medicine Comes to Thyroidology.精准医学进入甲状腺领域。

J Clin Endocrinol Metab. 2016 Mar;101(3):799-803. doi: 10.1210/jc.2015-3695. Epub 2016 Feb 23.

Thyroid cancer diagnosis in the era of precision imaging.精准成像时代的甲状腺癌诊断

J Thorac Dis. 2020 Sep;12(9):5128-5139. doi: 10.21037/jtd.2019.08.37.

RET gene mutational diagnosis and precision medicine in Mexico.墨西哥的 RET 基因突变诊断与精准医学。

Gac Med Mex. 2022;158(3):150-156. doi: 10.24875/GMM.M22000658.

A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the European Thyroid Association, the Society of Nuclear Medicine and Molecular Imaging on Current Diagnostic and Theranostic Approaches in the Management of Thyroid Cancer.美国甲状腺协会、欧洲核医学协会、欧洲甲状腺协会、核医学与分子影像学学会关于甲状腺癌管理中当前诊断和治疗方法的联合声明

Thyroid. 2021 Jul;31(7):1009-1019. doi: 10.1089/thy.2020.0826. Epub 2021 Jun 23.

Theranostics in Thyroid Cancer.甲状腺癌的治疗策略。

PET Clin. 2021 Jul;16(3):375-382. doi: 10.1016/j.cpet.2021.03.007.

引用本文的文献

Radio-iodine refractory thyroid cancer patients: a tailored follow-up based on clinicopathological features.放射性碘难治性甲状腺癌患者：基于临床病理特征的个体化随访。

J Endocrinol Invest. 2023 Oct;46(10):2165-2173. doi: 10.1007/s40618-023-02076-6. Epub 2023 Apr 21.

本文引用的文献

Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: implications in precision oncology-a narrative review.甲状腺癌中端粒酶逆转录酶启动子突变：对精准肿瘤学的影响——一篇叙述性综述

Ann Transl Med. 2020 Oct;8(19):1244. doi: 10.21037/atm-20-5024.

Comparison of iPTH and calcium levels between total thyroidectomy and lobectomy: a prospective study of 840 thyroid cancers with three years of follow-up.全甲状腺切除术与甲状腺叶切除术患者甲状旁腺激素（iPTH）和血钙水平比较：一项对840例甲状腺癌患者进行三年随访的前瞻性研究。

Ann Transl Med. 2020 Oct;8(19):1243. doi: 10.21037/atm-20-4554.

Analysis of the strategy of LT4 prescribing and TSH monitoring for thyroid carcinoma after lobectomy.甲状腺癌肺叶切除术后左甲状腺素（LT4）处方策略及促甲状腺激素（TSH）监测分析

Ann Transl Med. 2020 Oct;8(19):1238. doi: 10.21037/atm-20-4890.

Effects of radioactive iodine treatment on cardiovascular disease in thyroid cancer patients: a nationwide cohort study.放射性碘治疗对甲状腺癌患者心血管疾病的影响：一项全国性队列研究。

Ann Transl Med. 2020 Oct;8(19):1235. doi: 10.21037/atm-20-5222.

Beta-elemene inhibits differentiated thyroid carcinoma metastasis by reducing cellular proliferation, metabolism and invasion ability.β-榄香烯通过降低细胞增殖、代谢和侵袭能力来抑制分化型甲状腺癌转移。

Ann Transl Med. 2020 Oct;8(19):1232. doi: 10.21037/atm-20-4460.

MiR-3121-3p promotes tumor invasion and metastasis by suppressing Rap1GAP in papillary thyroid cancer .微小RNA-3121-3p通过抑制甲状腺乳头状癌中的Rap1GAP促进肿瘤侵袭和转移。

Ann Transl Med. 2020 Oct;8(19):1229. doi: 10.21037/atm-20-4469.

Mitotically associated long non-coding RNA is a tumor promoter in anaplastic thyroid cancer.有丝分裂相关长链非编码RNA是间变性甲状腺癌中的一种肿瘤促进因子。

Ann Transl Med. 2020 Oct;8(19):1226. doi: 10.21037/atm-20-4530.

Genetic alterations in cfDNA of benign and malignant thyroid nodules based on amplicon-based next-generation sequencing.基于扩增子二代测序技术的良恶性甲状腺结节游离DNA的基因改变

Ann Transl Med. 2020 Oct;8(19):1225. doi: 10.21037/atm-20-4544.

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。

CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.

TERT promoter mutations in thyroid cancer.甲状腺癌中的端粒酶逆转录酶（TERT）启动子突变

Endocr Relat Cancer. 2016 Mar;23(3):R143-55. doi: 10.1530/ERC-15-0533. Epub 2016 Jan 5.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验